Is there still a role for neoadjuvant therapy in breast cancer?
- 31 January 2003
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 45 (1), 77-90
- https://doi.org/10.1016/s1040-8428(02)00091-4
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Neoadjuvant chemotherapy in 126 operable breast cancersEuropean Journal Of Cancer, 1992
- Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cmAnnals of Oncology, 1991
- Primary systemic therapy for operable breast cancerBritish Journal of Cancer, 1991
- Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancerCancer, 1990
- Primary medical therapy for operable breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapyCancer, 1988
- Multimodal treatment of locoregionally advanced breast cancerCancer, 1983
- Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancerCancer Chemotherapy and Pharmacology, 1978